"Central America Pharmaceuticals & Healthcare Report Q1 2014" Now Available at Fast Market Research
Despite the delicate macroeconomic situation in Central America, the pharmaceutical market -consisting of the seven markets of Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama and Belize - is set to grow. Local authorities' emphasis on healthcare investment should translate into higher consumption of medicines. However, the region's low per capita pharmaceutical spending and generic drugs' high market share has limited multinationals' growth potential in the region.
View full press release